Live attenuated Japanese encephalitis virus; Yellow fever virus
H-040-006
Phase 2 mab completed
Quick answer
Live attenuated Japanese encephalitis virus; Yellow fever virus for Japanese Encephalitis is a Phase 2 program (mab) at Sanofi Pasteur with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pasteur
- Indication
- Japanese Encephalitis
- Phase
- Phase 2
- Modality
- mab
- Status
- completed